Tetronal
Overview[edit]
Tetronal is a sedative and hypnotic drug that belongs to the class of barbiturates. It was first synthesized in the early 20th century and was used primarily for its calming effects and ability to induce sleep. Like other barbiturates, Tetronal acts on the central nervous system to produce its effects.
Chemical Structure[edit]

Tetronal is chemically known as 5,5-diethyl-2-thioxo-4,6(1H,5H)-pyrimidinedione. The structure of Tetronal includes a pyrimidine ring with two ethyl groups attached at the 5th position and a thioxo group at the 2nd position. This structure is typical of barbiturates, which are derivatives of barbituric acid.
Mechanism of Action[edit]
Tetronal, like other barbiturates, works by enhancing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter in the brain. GABA is the primary inhibitory neurotransmitter in the central nervous system, and its activation leads to increased chloride ion influx into neurons, resulting in hyperpolarization and decreased neuronal excitability. This action produces the sedative and hypnotic effects of Tetronal.
Uses[edit]
Historically, Tetronal was used to treat insomnia, anxiety, and seizures. However, due to the development of safer and more effective medications, its use has declined significantly. Today, Tetronal is rarely used in clinical practice and is primarily of historical interest.
Side Effects[edit]
The use of Tetronal can lead to several side effects, including drowsiness, dizziness, nausea, and respiratory depression. In higher doses, it can cause coma and death due to its potent depressant effects on the central nervous system. Long-term use can lead to tolerance, dependence, and withdrawal symptoms.
History[edit]
Tetronal was first synthesized in the early 1900s and was one of the many barbiturates developed during that time. It was used extensively until the mid-20th century when benzodiazepines and other safer sedatives became available. The decline in its use was also due to the high risk of overdose and addiction associated with barbiturates.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian